Skip to main content

NHS: Drugs

Volume 499: debated on Wednesday 11 November 2009

To ask the Secretary of State for Health what drugs used in the NHS are known to have teratogenic effects; and if he will make a statement. (297456)

Drugs can have harmful effects (teratogenic effects) on the foetus at any time during pregnancy, with the period of greatest risk being from the third to the eleventh week of pregnancy.

The safety, efficacy and quality of each new medicine is thoroughly evaluated as part of the licensing procedure. European guidelines define the types of tests which should be undertaken, including those that assess the potential harm to a developing foetus.

The available information is reflected in the product information for each medicine which contains a specific section that summarises the information in relation to safety of use during pregnancy. This is kept under review to ensure patients and prescribers are given accurate up to date information. A summary source of this information is appendix 4 of the British National Formulary (BNF). The BNF is provided free to prescribers and pharmacists within the NHS.